Piper Jaffray initiates coverage on Sunesis Pharmaceuticals (NASDAQ: SNSS) with a Buy rating and a $3 price target.

This article: 146 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE